The American Centers for Disease Control and Prevention (CDC) recognizes Acinetobacter baumannii as a source of global outbreaks and epidemics especially due to its increasing resistance to commercially available antibiotics. In this study, 69 single patient multidrug resistant isolates collected from all over Palestine, except Gaza, were studied. All the isolates were resistant to all the -lactam antibiotics including the carbapenems. Of the 69 isolates, 82.6% were positive for OXA-23 , 14.5% were positive for OXA-24 , and 3% were positive for OXA-58 . None were positive for OXA-143 and OXA-235 . In addition, 5.8% and 0% were positive for NDM and KPC , respectively. Of the 69 isolates, none were positive for the aminoglycoside aphA6 gene while 93% were positive for the aphA1 gene. The acetyltransferases aacC1 and aacA4 genes tested positive in 22% and 13% of the isolates, respectively. The ompA biofilm-producing virulence gene was detected in all isolates. Finally, Multilocus Sequence Typing (MLST) of 13 isolates revealed that more than one strain of A. baumannii was circulating in Palestinian hospitals as results revealed that 7 isolates were of ST208, 2 isolates ST218, 1 isolate ST231, 1 isolate ST348, and 2 new Sequence Types. The detection of these drug resistant pathogens is a reminder of the importance of active surveillance for resistant bacteria in order to prevent their spread in hospital settings.
Introduction
Acinetobacter baumannii is a gram-negative, nonfermentative, oxidase-negative coccobacillus. The Centers for Disease Control and Prevention (CDC) recognizes multidrug resistant (MDR) A. baumannii as a source of global outbreaks and epidemics especially due to its effectiveness in colonizing hospital environments and due to its increasing resistance to commercially available antibiotics, including -lactams, fluoroquinolones, tetracyclines, and aminoglycosides [1] [2] [3] . A. baumannii is associated with hospital-acquired infections which include ventilator-associated pneumonia, bloodstream infections, meningitis, and urinary tract infections (UTI's) [3] .
Mechanisms of resistance in Acinetobacter strains include efflux pumps, -lactamases, and modifications in porin proteins. A. baumannii expresses aminoglycoside-modifying enzymes (AMEs) making them resistant to aminoglycoside antibiotics. Moreover, mutations in the gyrA and parC genes make them resistant to quinolones [1] . Worthy of mention are the findings of Fournier et al. (2006) who identified AbaR1 resistance islands (86 kb region) encompassing a cluster of resistance genes, namely, ones coding for tetracycline efflux pumps, several AMEs, AmpC, and OXA-10 -lactamases.
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Genetic analysis of this region also indicated the presence of transposons and genes formerly identified in Salmonella spp. and E. coli [4] .
Enzymatic degradation by -lactamases is the most prevalent mechanism of -lactam resistance in A. baumannii. Serine oxacillinases (Ambler class D OXA-type) and metallo--lactamases (MBLs) (Ambler class B) are -lactamases with carbapenemase activity. OXA-type carbapenemase genes in Acinetobacter can be classified into different phylogenetic subgroups:
OXA-23 , OXA-24 , OXA-51 , OXA-58 , , and OXA-235 [5, 6] . The emergence of carbapenem-resistant strains associated with OXA-type -lactamases is increasing as well as their contribution to outbreaks and patient mortality [7] . Another group of recently discovered -lactamases in Acinetobacter is the class B -lactamase NDM and the class A serine carbapenemase KPC both have a great opportunity to spread to other bacteria due to their location on mobile genetic elements [8] .
In addition, A. baumannii has other virulence factors that aid in its protection and survival. It has the ability to form biofilms, which are essentially aggregates in which the cells adhere to each other and to a surface in a self-produced matrix of extracellular DNA, polysaccharides and proteins [1] . In A. baumannii, outer membrane protein A (ompA) is involved in biofilm formation on abiotic surfaces [9] . Biofilm formation not only helps protect the bacteria against disinfection for instance, but also helps in trading resistance genes between the participating cells.
In this study, we performed in-depth characterization of extremely resistant nonduplicated A. baumannii strains isolated from samples of hospitalized patients from all over Palestine except Gaza.
Materials and Methods

Ethical
Considerations. This study was approved by the Medical Research Committee at Caritas Baby Hospital (MRC-014) in Bethlehem, Palestine.
Study Population. Extremely drug resistant A. baumannii
isolates, all resistant to carbapenems, were collected from 69 patients from Palestinian hospitals all over Palestine with the exception of the Gaza strip. Isolates were collected from five Palestinian districts as follows: Jerusalem ( = 2), Bethlehem ( = 22), Hebron ( = 34), Nablus ( = 8), and Ramallah ( = 3). The isolates were collected between January 2006 and February 2014 from blood, urine, sputum, and rectal samples.
A. baumannii Species Identification. In order to identify
A. baumannii from the collected Acinetobacter spp. isolates, all isolates were identified biochemically and screened for the naturally occurring carbapenemase gene ( OXA-51 ) intrinsic to A. baumannii using polymerase chain reaction (PCR) as previously reported [10, 11] . Gene. The isolates were screened for the presence of the IS element, ISAba1, and analyzed for the potential expression of the OXA-51 gene by investigating the presence of the ISAba1 element upstream of the gene [12] .
Presence of ISAba1 Element and the Expression of
Antibiotic Susceptibility
Testing. Antibiotic susceptibility testing (AST) by disk diffusion test was performed for the following antibiotics (ceftazidime 30 g, cefotaxime 30 g, ceftriaxone 30 g, piperacillin-tazobactam 100/10 g, cefepime 30 g, sulfamethoxazole 25 g, amikacin 30 g, gentamycin 10 g, ciprofloxacin 5 g, meropenem 10 g, and imipenem 10 g). In addition, the minimal inhibitory concentration of the two antibiotics meropenem and colistin were determined by Etest (BioMérieux, Marcy-l'Étoile, France). AST was performed and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [13] .
Detection of Antibiotics Resistant
Genes and the BiofilmProducing ompA Gene. Carbapenem-and aminoglycosideresistant determinants as well as biofilm-producing virulence factors were screened for using standard PCR assay using a PTC-100 Peltier Thermal Cycler (Bio-Rad, USA). The PCR products were then subjected to gel electrophoresis on 1.5% agarose gel for 45 minutes at 85 V and viewed under UV light using the Transilluminator imaging device (Dinco & Rhenium Industries Ltd., Israel). Target genes and their corresponding primers for PCR amplification are mentioned in Table 1 . All PCR reactions were done in singleplex with the exception of the OXA-type class D carbapenemases ( OXA-23 , OXA-24 , and OXA-58 ) which were done in a multiplex PCR reaction as reported in Mostachio et al. (2009) . The assays were held in 25 l volume reactions containing 2x ReddyMix PCR Master Mix with 1.5 mM MgCl 2 (Thermo Fisher Scientific, USA) with a primer concentration of 20 pmol/ l at standard PCR conditions. A PTC-100 Peltier Thermal Cycler (Bio-Rad, USA) was used for the PCR amplification reactions. ∘ C for all genes. A PTC-100 Peltier Thermal Cycler (Bio-Rad, USA) was used for the PCR amplification reactions. PCR products were analyzed on a 1.5% agarose gel and visualized using UV light using the Transilluminator imaging device (Dinco & Rhenium Industries Ltd., Israel). Amplified PCR products with the appropriate size were purified using the High Pure PCR Product Purification Kit (Roche) and sequenced using the BigDye5 Terminator v3.1 Cycle Sequencing Kit (Life Technology, Carlsbad, USA). The sequences were analyzed and cleaned using Sequencher5 software (Gene Codes, MI, USA) and the PubMLST database. Isolates were assigned sequence types (STs) as per the allelic profiles in the A. baumannii MLST database (https://pubmlst.org/abaumannii/). The eBURST V3 algorithm (http://eburst.mlst.net/) was used to show phylogenetic relationships among related STs.
Multilocus Sequence Typing (MLST)
.
Results
Acinetobacter Species Identification.
OXA-51 PCR amplification confirmed that all 69 isolates were A. baumannii. Gene. Of the 69 isolates, 68 (99%) carried the ISAba1 element. Of these, only 30 (43.5%) had the IS element upstream of the OXA-51 gene.
Presence of ISAba1 Element and the Expression of
3.3.
A. baumannii Susceptibility Testing. All isolates had a multidrug resistant profile, and they were all resistant to alllactam antibiotics including the carbapenems (Figure 1) . The carbapenem resistance profile of all isolates was confirmed by determining the MIC value of meropenem by Etest method (BioMérieux, Marcy-l'Étoile, France). The only class of antibiotics to which the isolates were susceptible was colistin sulfate (100%) (Figure 1 ). In addition, the majority of A. baumannii isolates (>90%) were resistant to the aminoglycosides, macrolides, and cotrimoxazole. 
Detection of Aminoglycoside-Resistant Genes.
Of the 69 isolates, 64 (93%) were positive for the aphA1 gene while none were positive for the aphA6 gene (Figure 3 ). On the other hand, the isolates were positive for the acetyltransferases aacC1 and aacA4 genes in 15 (22%) and 9 (13%) of the isolates, respectively. None were positive for the nucleotidyltransferases aadB or aadA1 genes (Figure 3 ).
Detection of Biofilm-Producing Virulence Factors.
Of the 69 A. baumannii isolates tested, all (100%) tested positive for ompA gene. 
Multilocus Sequence Typing (MLST
Discussion
A. baumannii has acquired a huge genetic repertoire via horizontal gene transfer that makes it virulent and resistant to any environmental pressures [1, 4] . Antibiotic susceptibility testing in this study showed that all A. baumannii isolates were resistant to the commercially available antibiotics with the exception of colistin. All isolates had an extremely drug resistant profile and they were resistant to carbapenems. MDR A. baumannii outbreaks were reported in hospitals worldwide including the Middle East [14, 15] and this is consistent with the increase in the incidence of health care associated A. baumannii infections reported in Palestinian and Israeli hospitals [2, 14, 15] . A. baumannii isolates from other geographical regions had a similar antimicrobial profile [16] . MIC tests also showed a similar result since most isolates were resistant to meropenem and sensitive to colistin. There are, however, A. baumannii isolates that are becoming resistant to colistin [3] . Studying the carbapenem-resistant mechanisms of this pathogen was necessary in order to better control the spread of A. baumannii and devise a better antibiotics treatment plan. Carbapenem resistance was mainly attributed to the presence of OXA genes that produce carbapenemhydrolyzing enzymes [5] . Since the OXA-51 gene is an oxacillinase naturally occurring mainly in A. baumannii, it was present in all A. baumannii isolates tested, and the potential expression of this gene in 43.5% of the isolates is facilitated by the ISAba1 element present upstream of the gene. The production of OXA-23 by an A. baumannii strain is enough to confer resistance to the carbapenems, and 82.6% of the isolates in this study carried this gene. This gene is plasmid-borne suggesting the mobility of this genetic segment facilitating horizontal gene transfer [5] .
OXA-23
was also reported in neighboring countries including Iraq, Greece, Italy, and Turkey [16] . Molecular class D -lactamases confer resistance to the carbapenems and narrow-spectrum cephalosporins. 14.5% of the isolates also carried the OXA-24 gene, and 3% of them carried the recently identified OXA-58 gene. This is also the case in neighboring countries as those class D -lactamases have been reported in Iraq, Kuwait, Lebanon, Turkey, Italy, Greece, and the UK [16] . Enzymatic degradation by -lactamases is the most prevalent mechanism of -lactam resistance in A. baumannii [7] , and this is clearly shown in our sampled A. baumannii isolates in the West Bank.
About 6% of our A. baumannii isolates tested positive for the class B carbapenemase NDM-1 . This is consistent with regional and global results as there are reports in Israel, India, China, United Kingdom, Canada, France, Sweden, Morocco, South Africa, United Arab Emirates, and Iran among many others [8] .
The multidrug resistant profile of the isolates was also heightened by the presence of aminoglycoside-resistant determinants, namely, the phosphotransferase aphA1 and the acetyltransferases aacC1 and aacA4. Almost all our isolates carried the aphA1 gene, and 22% and 13% were positive for aacC1 and aacA4 genes, respectively. In comparison to other studies, Aliakbarzade et al. (2014) reported the following aminoglycoside-resistant genes in Iran: aacC1, aadA1, aphA6, and aadB. Only aacC1 was detected in our Palestinian isolates, and none of our isolates carried the phosphotransferase aphA6. The aminoglycoside-resistant gene aphA6 was reported in Egypt [17] . On a more international scale, the following aminoglycoside-resistant genes were reported in Poland in 2013: aphA1, aphA6, and aacC1 [18] . Our isolates are equipped with not only enzymatic resistance mechanisms, but also the ompA biofilm-producing virulence factor. It is There is an apparent global outbreak of carbapenemresistant A. baumannii especially in the last decade. MLST is a discriminative typing method whose data are in concordance with other typing results produced by PFGE and AFLP analysis [5] . We sequence typed 13 isolates that are representative samples from different areas and different time periods throughout the West Bank. Sequence analysis of Palestinian genotypes showed a similarity with the global genotypes. Our MLST results reveal that more than one strain of A. baumannii is circulating in our Palestinian hospitals; the resulting STs were ST208, ST218, ST231, ST348, and two new STs. We correlated the STs with the timeline of their isolation and preliminary results show that there is a successful spread of clone. To illustrate, ST208 is evident throughout the studied time period, starting in 2008 up till 2014, indicating a successful spread of that particular strain. Internationally, ST208 was reported in the US in 2009, then in Egypt the following year, and then in China in 2012 [19] . The eBURST V3 algorithm [20] shows the relationship between the closely related isolates in which the founding genotype starts to diversify producing a cluster of closely related genotypes as it increases in frequency in the population. In summary, there is more than one clone of A. baumannii circulating worldwide as shown by the sequence analysis of our Palestinian genotypes and the global genotypes.
Resistance to antibiotics, resistance to disinfectants, and resistance to desiccation accompanied by the presence of drug resistant and biofilm-producing genes all contribute to the persistence of A. baumannii as a hospital pathogen. Resistant A. baumannii strains have a selective advantage in environments like the ICU's where antimicrobials and surface disinfectants are extensively used. Selection for resistant forms can take place during antimicrobial treatment or after treatment. There is a sense of altered microbial ecology with regard to resistant and susceptible bacteria as well as the types of microorganisms surviving after treatment.
Epidemiologically, A. baumannii is of concern due to its dissemination mostly in a clonal fashion whether it is within health care institutions and cities or globally between countries. Since A. baumannii is easily transmitted and can, therefore, cause outbreaks, certain control measures have to be taken into account. To start with, health care facilities and personnel should follow the CDC's infection control guidelines and protocols, which attempt to control and prevent the transmission of MDR organisms, such as active surveillance, hand hygiene, and contact precautions [19] . Molecular epidemiological studies should be implemented to determine the presence or absence of a clonal outbreak strain such as A. baumannii ST208 which appears to be a very successful clone. Proper environmental cleaning of potential reservoir sources present in hospital environments such as ventilators, catheters, containers, and moist articles is highly recommended to prevent the spread of Acinetobacter. Moreover, antibiotic stewardship programs must be initiated in order to properly manage treatment and spread of this deadly pathogen.
